190 related articles for article (PubMed ID: 26415140)
1. CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis.
Huang H; Wu T; Mao J; Fang Y; Zhang J; Wu L; Zheng S; Lin B; Pan H
OMICS; 2015 Jun; 19(6):339-45. PubMed ID: 26415140
[TBL] [Abstract][Full Text] [Related]
2. Expression of chitinase-3-like protein 1 in different TCM syndromes and its correlation with liver fibrosis.
Li H; Xu X; Yi T; Zheng T; Yan T
Ann Palliat Med; 2022 Jan; 11(1):217-224. PubMed ID: 35144413
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis].
Li H; Yan T; Zhu Z; Bao ZW; Xu TM; Xie J; Zheng SQ; Cui MM; Liu LG
Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):337-341. PubMed ID: 29996200
[No Abstract] [Full Text] [Related]
4. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
5. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B.
Liu J; Ji Y; Ai H; Ning B; Zhao J; Zhang Y; Dun G
Korean J Radiol; 2016; 17(3):396-404. PubMed ID: 27134527
[TBL] [Abstract][Full Text] [Related]
6. Serum CHI3L1 as a Biomarker for Non-invasive Diagnosis of Liver Fibrosis.
Bao J; Ouyang Y; Qiao L; He J; Liu F; Wang Y; Miao L; Fu A; Lou Z; Zang Q; Huang W; Huang J; Li Z
Discov Med; 2022; 33(168):41-49. PubMed ID: 36274212
[TBL] [Abstract][Full Text] [Related]
7. [Serum fibrosis markers in diagnosing liver fibrosis].
Liu J; Wang JY; Lu Y
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
[TBL] [Abstract][Full Text] [Related]
8. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
10. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China.
Jin X; Fu B; Wu ZJ; Zheng XQ; Hu JH; Jin LF; Tang LL
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):384-389. PubMed ID: 32540209
[TBL] [Abstract][Full Text] [Related]
11. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.
Rath T; Roderfeld M; Güler C; Wenzel C; Graf J; Beitinger F; Roeb E; Zachoval R
Scand J Gastroenterol; 2011 Nov; 46(11):1369-80. PubMed ID: 21905976
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.
Lee CK; Perez-Atayde AR; Mitchell PD; Raza R; Afdhal NH; Jonas MM
J Pediatr; 2013 Oct; 163(4):1058-64.e2. PubMed ID: 23759423
[TBL] [Abstract][Full Text] [Related]
15. Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.
Zhou Y; He CH; Herzog EL; Peng X; Lee CM; Nguyen TH; Gulati M; Gochuico BR; Gahl WA; Slade ML; Lee CG; Elias JA
J Clin Invest; 2015 Aug; 125(8):3178-92. PubMed ID: 26121745
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of serum collagen type IV in diagnosing liver fibrosis].
Feng X; Shen D; Wang J
Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):439-42. PubMed ID: 8556921
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
18. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.
Mehta P; Ploutz-Snyder R; Nandi J; Rawlins SR; Sanderson SO; Levine RA
Am J Gastroenterol; 2008 Apr; 103(4):928-36. PubMed ID: 18371145
[TBL] [Abstract][Full Text] [Related]
20. Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.
Bao S; Zheng J; Li N; Huang C; Chen M; Cheng Q; Yu K; Chen S; Zhu M; Shi G
Gut Liver; 2017 Nov; 11(6):860-869. PubMed ID: 28750488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
